Lawrence Shirley, MD
Surgical Oncology · Lexington, KYNPI 1205046620
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,109 of the $3,483 with a category attached, or 60.5%. Intuitive Surgical accounts for 72.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $1,570 and has fallen 74.3% since, to $404 in 2025.
Across 45 payments — averaging $77.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Davol Inc.$681
- AstraZeneca$68
- Innovation Technologies Inc$44
- TELA Bio, Inc.$24
- Takeda Pharmaceuticals U.S.A., Inc.$23
- plus $110 from 6 others
What the payments were for
- Travel & lodging$2,10961%
- Food & beverage$1,30637%
- Education$682%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $2,532 |
| Davol Inc. | 12 | $681 |
| AstraZeneca | 1 | $68 |
| Innovation Technologies Inc | 1 | $44 |
| TELA Bio, Inc. | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $21 |
| Novartis | 1 | $20 |
| Innocoll Pharmaceuticals Limited | 1 | $16 |
| Solventum Corporation | 1 | $15 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,296
- Phasix Mesh$187
- PHASIX$129
How this compares
$3,483 in reported general payments places this provider in the 60th percentile of 29 surgical oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 100 | $1,051 |
| Calcitriol | 18 | $482 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 93 | $207 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Lexington
- Jennifer WhittingtonLexington$22K
- Prakash PandalaiLexington$8K
- Veronica JonesLexington$4K
- Andrei CocieruLexington$3K
- Irada Ibrahim-ZadaLexington$2K
- Michael CavnarLexington$2K
- Leah WinerLexington$1K
- Sean StokesLexington$849
- Mautin Barry-HundeyinLexington$627
- Patrick McGrathLexington$271
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.